Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
ValiRx Share News (VAL)
VAL Share
Price
VAL Share
News
VAL Share
Chat
VAL Share
Trades8
VAL
Live RNS
VAL Share
Charts
VAL Level 2
Console
VAL Live
Share Price
VAL Broker
Ratings
VAL Directors
Deals
VAL Financial
Diary
VAL
Fundamentals
VAL Short
Positions
VAL
Media
VAL Company
Research
VAL Company
Timeline
Share Price Information for ValiRx (VAL)
Last checked at -
Last checked at 
Intraday ValiRx Share Chart
ValiRx VAL201 PhaseI/II Trial Progressing In Line With Plan
LONDON (Alliance News) - ValiRx PLC said Monday that its phase I/II trial of developmental prostate cancer treatment VAL201 is progressing as announced and on schedule with its plan.
The life sciences company has made full details of the trial available on the US National Institutes of Health searchable database as is legally required immediately before application of the trial substance to human beings.
Preliminary outcomes from the first cohort of the trial are expected in the first quarter of 2015.
Shares in ValiRx are trading up 8.6% at 0.380 pence Monday morning.
By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews
Copyright 2014 Alliance News Limited. All Rights Reserved.
Latest VAL News
- TRADING UPDATES: Maintel fundraising completes; ValiRx ends deal
22 Jun 2026 - IN BRIEF: ValiRx subsidiary Cytolytix granted "core" European patent
27 May 2026 - TRADING UPDATES: IAG launches new buyback; Forgent settles legal case
15 May 2026 - WINNERS & LOSERS: Kendrick drilling results; Blackbird new approach
15 May 2026 - WINNERS & LOSERS: Auction upgrades guidance; Aquila talks break down
14 May 2026 - IN BRIEF: ValiRx establishes veterinary oncology-focused subsidiary
3 Mar 2026 - TRADING UPDATES: Life Science REIT portfolio valuation declines 7.8%
9 Jan 2026 - TRADING UPDATES: Unilever targets early December Ice Cream spin-off
4 Nov 2025
Related News
TRADING UPDATES: Maintel fundraising completes; ValiRx ends deal
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
IN BRIEF: ValiRx subsidiary Cytolytix granted "core" European patent
ValiRx PLC - London-based life science company - Majority-owned subsidiary Cytolytix Ltd has its European patent "Nanoparticle for Anti-Cancer Peptide...
TRADING UPDATES: IAG launches new buyback; Forgent settles legal case
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:
ValiRx News
TRADING UPDATES: Maintel fundraising completes; ValiRx ends deal
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
IN BRIEF: ValiRx subsidiary Cytolytix granted "core" European patent
ValiRx PLC - London-based life science company - Majority-owned subsidiary Cytolytix Ltd has its European patent "Nanoparticle for Anti-Cancer Peptide...
TRADING UPDATES: IAG launches new buyback; Forgent settles legal case
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:
WINNERS & LOSERS: Kendrick drilling results; Blackbird new approach
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday.
WINNERS & LOSERS: Auction upgrades guidance; Aquila talks break down
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday.
IN BRIEF: ValiRx establishes veterinary oncology-focused subsidiary
ValiRx PLC - London-based life science company - Establishes wholly owned subsidiary ValiRx Animal Health Ltd to develop and commercialise its oncolog...
TRADING UPDATES: Life Science REIT portfolio valuation declines 7.8%
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:
TRADING UPDATES: Unilever targets early December Ice Cream spin-off
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:
Follow the stocks
